These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21058896)

  • 1. Burden of illness of hypertension among women using menopausal hormone therapy: a US perspective.
    Hawkins K; Mittapally R; Chang J; Nahum GG; Gricar J
    Curr Med Res Opin; 2010 Dec; 26(12):2823-32. PubMed ID: 21058896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of comorbidities in patients with psoriasis is substantial.
    Kimball AB; Guérin A; Tsaneva M; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):157-63. PubMed ID: 20561129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the impact and burden of illness of adult chronic ITP in the US.
    Saleh MN; Fisher M; Grotzinger KM
    Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
    Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
    Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy: a review of the risk versus benefit--Part II.
    Oates MB; McGhan WF; Smith MD
    Med Interface; 1997 Jan; 10(1):108-14. PubMed ID: 10164503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension: prevalence and economic implications.
    Dalzell MD
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):6-11. PubMed ID: 12971587
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing the economic burden of breast cancer in a US managed care population.
    Barron JJ; Quimbo R; Nikam PT; Amonkar MM
    Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic impact of symptomatic menopause among low-socioeconomic women in the United States.
    Keshishian A; Wang Y; Xie L; Baser O
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):305-13. PubMed ID: 26289732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undertreatment of menopausal symptoms and novel options for comprehensive management.
    Lewis V
    Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
    Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of dry eye disease in the United States: a decision tree analysis.
    Yu J; Asche CV; Fairchild CJ
    Cornea; 2011 Apr; 30(4):379-87. PubMed ID: 21045640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
    Hing E; Brett KM
    Obstet Gynecol; 2006 Jul; 108(1):33-40. PubMed ID: 16816053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopause management: a cardiovascular risk-based approach.
    Haines CJ; Farrell E
    Climacteric; 2010 Aug; 13(4):328-39. PubMed ID: 20001565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
    Manley HJ; Cannella CA
    Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.